Advanced cytoreductive surgery in gynecologic oncology Introduction

被引：4
作者：
Bristow, Robert E. [1 ]
机构：
[1] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Dept Gynecol & Obstet, Kelly Gynecol Oncol Serv, Baltimore, MD 21287 USA
来源：
GYNECOLOGIC ONCOLOGY | 2009年 / 114卷 / 02期
关键词：
ADVANCED OVARIAN-CANCER; IV EPITHELIAL OVARIAN; SURGICAL EFFORT; FALLOPIAN-TUBE; CARCINOMA; SURVIVAL; METAANALYSIS;
D O I：
10.1016/j.ygyno.2008.11.005
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1 / S2
页数：2
相关论文
共 18 条
[1]   Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Gostout, BS ;
Jones, MB ;
Stanhope, CR ;
Wilson, TO ;
Podratz, KC ;
Cliby, WA .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85
[2]   Intraperitoneal cisplatin and paclitaxel in ovarian cancer [J].
Armstrong, DK ;
Bundy, B ;
Wenzel, L ;
Huang, HQ ;
Baergen, R ;
Lele, S ;
Copeland, LJ ;
Walker, JL ;
Burger, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (01) :34-43
[3]   Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer [J].
Axtell, Allison E. ;
Lee, Margaret H. ;
Bristow, Robert E. ;
Dowdy, Sean C. ;
Cliby, William A. ;
Raman, Steven ;
Weaver, John P. ;
Gabbay, Mojan ;
Ngo, Michael ;
Lentz, Scott ;
Cass, Ilana ;
Li, Andrew J. ;
Karlan, Beth Y. ;
Holschneider, Christine H. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (04) :384-389
[4]   Stage IVB endometrial carcinoma: The role of cytoreductive surgery and determinants of survival [J].
Bristow, RE ;
Zerbe, MJ ;
Rosenshein, NB ;
Grumbine, FC ;
Montz, FJ .
GYNECOLOGIC ONCOLOGY, 2000, 78 (02) :85-91
[5]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[6]   Delaying the primary surgical effort for advanced ovarian cancer: A systematic review of neoadjuvant chemotherapy and interval cytoreduction [J].
Bristow, Robert E. ;
Eisenhauer, Eric L. ;
Santillan, Antonio ;
Chi, Dennis S. .
GYNECOLOGIC ONCOLOGY, 2007, 104 (02) :480-490
[7]   What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? [J].
Chi, D. S. ;
Eisenhauer, E. L. ;
Lang, J. ;
Huh, J. ;
Haddad, L. ;
Abu-Rustum, N. R. ;
Sonoda, Y. ;
Levine, D. A. ;
Hensley, M. ;
Barakat, R. R. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :559-564
[8]   Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach [J].
Chi, DS ;
Franklin, CC ;
Levine, DA ;
Akselrod, F ;
Sabbatini, P ;
Jarnagin, WR ;
DeMatteo, R ;
Poynor, EA ;
Abu-Rustum, NR ;
Barakat, RR .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :650-654
[9]   The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer [J].
Eisenhauer, Eric L. ;
Abu-Rustum, Nadeem R. ;
Sonoda, Yukio ;
Levine, Douglas A. ;
Poynor, Elizabeth A. ;
Aghajanian, Carol ;
Jarnagin, William R. ;
DeMatteo, Ronald P. ;
D'Angelica, Michael I. ;
Barakat, Richard R. ;
Chi, Dennis S. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (03) :1083-1090
[10]   Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study [J].
Eisenkop, SM ;
Friedman, RL ;
Wang, HJ .
GYNECOLOGIC ONCOLOGY, 1998, 69 (02) :103-108
12